Document:

Exhibit 10.1

 

 

THIS EXECUTIVE
CONSULTING AGREEMENT (this “Agreement”), dated as of June 29, 2020, (the “Effective Date”),
is entered into by and among SolarWindow Technologies, Inc. (the “Company”), Vector Asset Management, Inc.,
a British Columbia, Canada corporation (“VAMI”), and the Assigned Consultant (as defined in the recitals below)
who is a signatory to this Agreement. The Company, VAMI and the Assigned Consultant are sometimes collectively referred to as the
“Parties” and individually as a “Party.”

 

Recitals:

 

WHEREAS, VAMI
is in the business of providing business operations and development; and financial resource services;

 

WHEREAS, the
VAMI and the Company are parties to that certain Consulting Agreement dated as of February 1, 2015 (the “Prior Agreement”)
pursuant to which VAMI through its sole stockholder and employee, Mr. Jatinder S. Bhogal (the “Assigned Consultant”),
was assigned by VAMI to provide, on its behalf, consulting services to the Company, which services included the Assigned Consultant’s
services as a member of the Company’s Board of Directors (the “Board”); and

 

WHEREAS, the
Company and VAMI desire to terminate the Prior Agreement and to enter into this Agreement so as to more fully provide for (i) an
expansion of the Assigned Consultant’s services to include, but not be limited to his service, on a full time basis, as the
Company’s President and Chief Executive Officer, as well as his continued service as a member of the Board and (ii) the compensation
for the Services (as defined in Section 2.1 below) to be provided.

 

NOW, THEREFORE,
in consideration of the mutual promises, covenants and undertakings contained herein, and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

 

1.       Term
of Agreement. The respective duties and obligations of the Parties under this Agreement (the “Consulting Relationship”)
shall commence on the Effective Date and shall continue until June 30, 2023 (the “Initial Term”), unless earlier
terminated as provided in Section 4 of this Agreement. Anything herein to the contrary notwithstanding either Party may
terminate this Agreement with or without cause at any time subject only to the notice provision set forth herein; provided, however,
that the Initial Term and any Extended Term (as defined below) of this agreement shall be automatically extended (any such extended
term being herein referred to as an “Extended Term”) annually thereafter for an additional year unless either
party hereto gives written notice of its intention to terminate this Agreement, upon the expiration of the Initial Term or the
Extended Term, at least 30 days prior to the expiration of the Initial Term or the Extended Term, as the case may be. Except as
otherwise amended in writing, all of the terms and conditions of this Agreement shall remain in full force and effect during any
Extended Term. The Initial Term together with any Extended Terms are collectively referred to as the “Consulting Term.”

 

2.       Engagement
and Duties Assigned Consultant.

 

2.1       Engagement;
General Duties and Responsibilities. The Assigned Consultant, through VAMI, is hereby engaged to hold the office of the President
and Chief Executive Officer of the Company during the Consulting Term. The Assigned Consultant shall have such duties and authority
consistent with the position of President and Chief Executive Officer and such other positions and responsibilities as may be assigned
to him from time to time by the Board, including, if, if requested by the Board, also serve as a member of the Board or as an officer
or director of any affiliate of the Company for no additional compensation, subject to and in accordance with the terms and conditions
of this Agreement.

 

    	 	1	 

     

    

 

2.2       Devotion
of Entire Time to the Business of Company. VAMI will cause, and the Assigned Consultant agrees to, devote his entire time and
best efforts to the performance of his duties for the Company (except for permitted vacation periods and reasonable periods of
illness or other incapacity), and the Assigned Consultant shall not, directly or indirectly, engage or participate in any other
employment or occupation, or in any activities which may conflict with his duties or the best interests of the Company. Notwithstanding
the foregoing, nothing herein shall preclude the Assigned Consultant from: (i) serving, with the prior written consent of
the Board, which consent may be withheld for any reason or no reason in the sole discretion of the Company’s Board, as a
member of the board of directors or as an advisor (or their equivalents in the case of a non-corporate entity) (each an “Outside
Service Capacity” and collectively, “Outside Service Capacities”), and in addition shall initially
shall serve in the Outside Service Capacities for the entities set forth on Exhibit 2.2 to this Agreement and (ii) engaging
in charitable activities and community affairs. The Board expressly reserves the right to withhold its consent to additional directorships
following the date hereof, and, in the event of an identified conflict of interest with respect to Assigned Consultant’s
duties and obligations to the Company, to withdraw its consent to (i) the Outside Service Capacities set forth on Exhibit
2.2 to this Agreement in the Board’s reasonable discretion and (ii) any other Outside Service Capacity approved by
the Board following the date hereof, in the Board’s sole discretion.

 

2.3       Place
of Performance. During the Term, the Assigned Consultant will be based in the Assigned Consultant’s home office, or from
time to time at the Company’s offices at its headquarters’ location; although, the Assigned Consultant acknowledges
and agrees that he may be required to travel to other locations, and to perform services in such other locations as requested by
the Company or as appropriate to performing his services for the Company.

 

3.       Compensation;
Benefits; Expense Reimbursements.

 

3.1       Base
Consulting Fee. VAMI shall receive an annual base consulting fee” as set forth on the compensation rider to this Agreement
(the “Compensation Rider”) and attached hereto as Exhibit 3.1 and made a part hereof (the “Base
Consulting Fee”).

 

3.2       Bonus
Consulting Fee. VAMI shall be eligible to receive an annual discretionary bonus fee as set forth on the Compensation Rider
to this Agreement and attached hereto as Exhibit 3.1 and made a part hereof (the “Discretionary Bonus Consulting
Fee”).

 

3.3       Stock
Option Grant.

 

3.3.1 The conditional
stock option granted VAMI on June 8, 2020 having the terms and conditions set forth on the Compensation Rider to this Agreement
and attached hereto as Exhibit 3.1 and made a part hereof (the “Stock Option”) shall be effective
as of July 1, 2020.

 

3.3.2 VAMI hereby assigns
and transfers the Stock Option to the Assigned Consultant and directs that the Stock Option be issued by the Company directly to
and in the name of the Assigned Consultant, as to which assignment, transfer and issuance the Company agrees.

 

3.4       Reimbursement
of Expenses. The Company shall reimburse VAMI, for pre-approved business expenses reasonably incurred by VAMI or the Assigned
Consultant in carrying out their respective responsibilities and obligations under this Agreement and promoting the Company’s
business will be reimbursed, including mileage and travel expenses in accordance with IRS guidelines within thirty days of submission
to the Company of appropriate documentation of such expenses and a description of the purpose of such expenses (an “Expense
Report”). Such Expense Report shall include the level of detail that is required of other Company executives generally.
Such reimbursement will be made within 30 days after the submission of such Expense Report. VAMI and the Assigned Consultant’s,
as applicable, reporting and expense reimbursement are governed by Company policies which are incorporated herein by reference
as may be amended from time to time during the Consulting Term and subject to monthly review of the Company’s finance and
accounting departments.

 

    	 	2	 

     

    

 

3.5        Withholding
Taxes. The Company shall withhold from any amounts payable to the to VAMI or the Assigned Consultant, as the case may be, any
amount it is required to withhold pursuant to applicable law.

 

 3.6        Clawback
Provisions. Notwithstanding any other provisions in this Agreement to the contrary, any incentive-based compensation, or any
other compensation, paid to VAMI pursuant to this Agreement or any other agreement or arrangement with the Company which is subject
to recovery under any law, government regulation, or stock exchange listing requirement, will be subject to such deductions and
clawback as may be required to be made pursuant to such law, government regulation, or stock exchange listing requirement (or any
policy adopted by the Company pursuant to any such law, government regulation or stock exchange listing requirement). 

 

4,       Termination of Consulting Relationship.
This Agreement and the Consulting Relationship hereunder may be terminated as follows:

 

4.1       Death.
Automatically and immediately, in the event of the death of the Assigned Consultant.

 

4.2       Permanent
Disability. If the Company determines in good faith that the Assigned Consultant has become Permanently Disabled, as defined
below, during the Consulting Term in which event the Company shall have the right to give the Assigned Consultant notice of its
intention to terminate his employment. In such event, the Assigned Consultant’s employment shall terminate effective as of
the 30th day from the date of such notice, provided that, within the 30-day period after such receipt, the Assigned Consultant
shall not have returned to full-time performance of his duties. For purposes of this Agreement, “Permanently Disabled”
shall mean the inability of the Assigned Consultant to perform the essential functions of one or more of his primary duties as
a result of his incapacity, despite any reasonable accommodation required by law, due to bodily injury or disease or any other
mental or physical illness, which inability continues for a period of one hundred eighty (180) days, which need not be consecutive,
within any three hundred sixty five (365) day period.

 

4.3       By
the Company For Cause. Automatically and immediately upon providing notice to the Assigned Consultant at the option of
the Company, after approval by the Board, for “Cause.” As used in this Agreement, “Cause”
shall mean, in each case as determined in good faith by the Board: (i) the commitment by VAMI or the Assigned Consultant of
any act involving fraud or moral turpitude, any act of dishonesty or breach of trust in connection with Assigned Consultant’s
duties or obligations to the Company, (ii) willful misconduct or gross negligence by the Assigned Consultant in the performance
of his duties to the Company, or refusal to comply with any reasonable direction of the Board, after the Assigned Consultant has
been notified of such event in writing and has had thirty (30) days from receipt of such notice to cure such event (if capable
of being cured), (iii) conviction of any felony, (iv) failure to deliver the Prior Inventions Schedule (as defined in Section
6.3.3), or (v) any material breach by Employee of his confidentiality and non-solicitation obligations to the Company.

 

4.4       By
the Company Without Cause. At the option of the Company, at any time without Cause on thirty (30) days’ prior
written notice thereof to the Assigned Consultant.

 

    	 	3	 

     

    

 

4.5       By
VAMI or the Assigned Consultant. At the option of VAMI or the Assigned Consultant, at any time on thirty (30) days’
prior written notice thereof to the Company.

 

4.6       Expiration
of Consulting Term. Automatically and immediately upon the expiration of the Employment Term following notice by either
the Company, VAMI or the Assigned Consultant of its or his intention not to renew this Agreement for an additional one-year term
pursuant to Section 1 of this Agreement.

 

5.       
Payments Upon Termination and Separation.

 

5.1       
Death. Upon the termination of this Agreement due to the Assigned Consultant’s death, VAMI shall be entitled
to receive only (i) the accrued and unpaid Base Annual Consulting Fee payable through the date of such termination; (ii) reimbursement
for reasonable business expenses necessarily incurred by VAMI or the Assigned Consultant in the ordinary course of their respective
duties and in accordance with the Company’s policies; (iii) a Prorated Discretionary Bonus Payment (as defined in the
Compensation Rider) (prorated for the period of time in which the Assigned Consultant was actively at work on a full-time basis),
if any; subsections (i) and (ii) of this Section 5.1 are hereinafter referred to as the “Accrued
Rights.” Following the termination of the Consulting Relationship and this Agreements due to the Assigned Consultant’s
death, except as set forth in this Section 5.1, neither VAMI nor the Assigned Consultant (and his legal representatives)
shall have any further rights to any compensation or any other benefits under this Agreement.

 

5.2       Permanent
Disability. Upon the termination of this Agreement due to the Assigned Consultant’s Permanently Disability pursuant
to Section 4.2, VAMI shall be entitled to receive the Accrued Rights and the Prorated Discretionary Bonus Payment (prorated
for the period of time in which the Assigned Consultant was actively at work on a full-time basis), if any. Following the termination
of the Consulting Relationship and this Agreements due to the Assigned Consultant’s being Permanently Disabled, except as
set forth in this Section 5.2, neither VAMI nor the Assigned Consultant (and his legal representatives) shall have
any further rights to any compensation or any other benefits under this Agreement.

 

5.3       Termination
for Cause. Upon the termination of this Agreement by the Company for Cause pursuant to Section 4.3, VAMI shall
be entitled to receive only the Accrued Rights. Following the termination of this Agreement by the Company for Cause, except as
set forth in this Section 5.3, neither VAMI nor the Assigned Consultant shall have any further rights to any compensation
or any other benefits under this Agreement.

 

5.4       Termination
Without Cause. Upon the termination of this Agreement by the Company without Cause pursuant to Section 4.4,
other than in connection with a Change of Control as specified in Section 5.6 below, VAMI shall be entitled to receive
(i) the Accrued Rights, and (ii) subject to delivery to the Company, by each of VAMI and the Assigned Consultant, of
an executed written general release of claims in favor of the Company and its affiliates in a form acceptable to the Company (the
“Release”) within 21 days following the date the Assigned Consultant has been given a copy of the Release, and
the expiration of the revocation period for such Release has become irrevocable by its terms within 7 days following the date VAMI
and the Assigned Consultant each returns the executed Release to the Company and, if the Assigned Consultant then should be a director
of the Company, the Assigned Consultant’s resignation from the Board in accordance with Section 5.7 hereof, (A) the
Prorated Bonus Payment; and (B) the Base Fee in effect at termination, for twelve (12) months, payable in accordance
with the normal payroll practices of the Company (collectively, the “Severance Benefit”). Following the termination
of this Agreement by the Company without Cause pursuant to Section 4.4, other than in connection with a Change of Control,
except as set forth in this Section 5.4, neither VAMI nor the Assigned Consultant shall have any further rights to
any compensation or any other benefits under this Agreement.

 

    	 	4	 

     

    

 

5.5       
Resignation of Assigned Consultant; Non-Renewal by the Assigned Consultant or the Company. Upon the termination of
this Agreement by the Assigned Consultant or VAMI, pursuant to Section 4.4 or the non-extension of the Initial
Term or any Extended Term pursuant to Section 1 by any Party, VAMI shall be entitled to receive only the Accrued Rights.
Following the termination of this Agreement by the Assigned Consultant or VAMI, pursuant to Section 4.4 or the
non-extension of the Initial Term or any Extended Term pursuant to Section 1 by any Party, except as set forth in this
Section 5.5, neither VAMI nor the Assigned Consultant shall have any further rights to any compensation or any
other benefits under this Agreement.

 

5.6       
Effect of Change of Control. In the event that, following a Change of Control (as defined below) this Agreement is
terminated by the Company without Cause prior to the later of (a) the first anniversary of the Effective Date, or (b) within twelve
(12) months of the Change of Control, then VAMI shall be entitled to receive (i) the Accrued Rights, (ii) the Prorated Bonus
Payment, if any and (iii) subject to VAMI and the Assigned Consulting delivering to the Company the Release, within 21 days
following the date the Assigned Consultant has been given a copy of the Release, and the expiration of the revocation period for
such Release has become irrevocable by its terms within 7 days following the date on which each of VAMI and the Assigned Consultant
returns the executed Release to the Company and, if the Assigned Consultant then should be a director of the Company, the Assigned
Consultant’s resignation from the Board in accordance with Section 5.7 hereof, an amount equal to the Base
Annual Consulting Fee in effect on the termination date multiplied by 1.5, which amount is payable in a lump sum within thirty
(30) days; and (iv) the termination without Cause occurs prior to the first anniversary of the Effective Date, the vesting
of all stock option grants set forth on Exhibit 3.1 regardless of date or condition of vesting, shall vest as of the date
of such termination.

 

If, upon the Change
of Control, (i) the Company shall cease to be a stand-alone publicly traded entity, or (ii) the acquiring entity is unwilling
to assume the equity in an economically equivalent manner, then in either event, all equity shall be deemed to have vested two
(2) days prior to the Change of Control, but only if such Change of Control shall actually be consummated. Following the termination
of this Agreement as described in this Section 5.6 or otherwise in connection with a Change of Control, except as set forth
in this Section 5.6, VAMI and the Assigned Consultant shall have no further rights to any compensation or any other benefits
under this Agreement.

 

For the purposes this
Agreement, “Change of Control” shall mean (i) the acquisition by any individual, entity or group (within
the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)),
other than any individual, entity or group which, as of the date of this Agreement, beneficially owns more than ten percent (10%) of
the then outstanding shares of common stock of the Company (the “Common Stock”), of beneficial ownership (within
the meaning of Rule 13d-3 promulgated under the Exchange Act) of fifty percent (50%) or more of the then outstanding Common
Stock; provided, however, that any acquisition by the Company or its subsidiaries, or any employee
benefit plan (or related trust) of the Company or its subsidiaries of fifty percent (50%) or more of outstanding Common Stock
shall not constitute a Change of Control, and provided, further, that any acquisition by an entity
with respect to which, following such acquisition, more than fifty percent (50%) of the then outstanding equity interests
of such entity, is then beneficially owned, directly or indirectly, by all or substantially all of the individuals and entities
who were the beneficial owners of the outstanding Common Stock immediately prior to such acquisition of the outstanding Common
Stock, shall not constitute a Change in Control; or (ii) the consummation of (a) a reorganization, merger or consolidation
(any of the foregoing, a “Merger”), in each case, with respect to which all or substantially all of the individuals
and entities who were the beneficial owners of the outstanding Common Stock immediately prior to such Merger do not, following
such Merger, beneficially own, directly or indirectly, more than fifty percent (50%) of the then outstanding shares of common stock
of the corporation resulting from Merger, or (iii) the sale or other disposition of all or substantially all of the assets
of the Company, excluding (a) a sale or other disposition of assets to a subsidiary of the Company; and (b) a sale or
other disposition of assets to any individual, entity or group which, as of the date of this Agreement, beneficially owns more
than ten percent (10%) of the then outstanding Common Stock.

 

    	 	5	 

     

    

 

5.7       
Board Resignation as a Condition Precedent. Assigned Consultant agrees, as a condition to the receipt of the termination
payments and benefits provided for in this Section 5, and notwithstanding giving the Release, that should Assigned
Consultant be a director of the Company he shall automatically be deemed to have resigned from the Board of the Company whether
or not such written resignation is tendered.

 

5.8       Termination
of Consulting Relationship. For avoidance of doubt, termination of this Agreement for any reason whatsoever shall constitute
an automatic termination of the Consulting Relationship unless the otherwise agreed in writing by the Parties.

 

6.       Confidential
Information and Invention Assignment Agreement.

 

6.1
       Applicability to Past Activities.
The Company, VAMI and the Assigned Consultant each acknowledge that VAMI and the Assigned Consultant
have performed work, activities, services or made efforts on behalf of or for the benefit of the Company, or related to the current
or prospective business of the Company in anticipation of VAMI and the Assigned Consultant’s involvement with the Company,
that would have been “services” if performed during the term of this agreement, for a period of time prior to the effective
date of this agreement, including, but not limited to the period covered by the Prior Agreement (the “Prior
Consulting Period”). Accordingly, if and to the extent that, during the Prior Consulting
Period: (i) VAMI and the Assigned Consultant received access to any information from or on behalf of the Company that would have
been confidential information (as defined below) if VAMI and the Assigned Consultant received access to such information during
the term of this Agreement; or (ii) VAMI and the Assigned Consultant (a) conceived, created, authored, invented, developed or reduced
to practice any item (including any intellectual property rights with respect thereto) on behalf of or for the benefit of the company,
or related to the current or prospective business of the Company in anticipation of VAMI and the Assigned Consultant’s involvement
with the Company, that would have been an invention (as defined below) if conceived, created, authored, invented, developed or
reduced to practice during the term of this agreement; or (b) incorporated into any such item any pre-existing invention, improvement,
development, concept, discovery or other proprietary information that would have been a prior invention (as defined below) if incorporated
into such item during the term of this agreement; then any such information shall be deemed “confidential information”
hereunder and any such item shall be deemed an “Invention” or “Prior
Invention” hereunder, and this Agreement shall apply to such activities, information or
item as if disclosed, conceived, created, authored, invented, developed or reduced to practice during the term of this Agreement.

 

6.2       Confidential
Information.

 

6.2.1       Protection
of Information. Each of VAMI and the Assigned Consultant understands that during the Consulting Relationship, the Company intends
to provide Assigned Consultant with certain information, including Confidential Information (as defined below), without which Consultant
would not be able to perform the Assigned Consultant’s duties to the Company. At all times during the term of the Consulting
Relationship and thereafter, Assigned Consultant shall hold in strictest confidence, and not use, except for the benefit of the
Company to the extent necessary to perform the Services, and not disclose to any person, firm, corporation or other entity, without
written authorization from the Company in each instance, any Confidential Information that Assigned Consultant obtains from the
Company or otherwise obtains, accesses or creates in connection with, or as a result of, the Services during the term of the Consulting
Relationship, whether or not during working hours, until such Confidential Information becomes publicly and widely known and made
generally available through no wrongful act of Assigned Consultant or of others who were under confidentiality obligations as to
the item or items involved. The Assigned Consultant shall not make copies of such Confidential Information except as authorized
by the Company or in the ordinary course of the provision of Services.

 

    	 	6	 

     

    

 

6.2.2       Confidential
Information. VAMI and the Assigned Consultant understand that “Confidential Information” means any and all
information and physical manifestations thereof not generally known or available outside the Company and information and physical
manifestations thereof entrusted to the Company in confidence by third parties, whether or not such information is patentable,
copyrightable or otherwise legally protectable. Confidential Information includes, without limitation: (i) Company Inventions (as
defined below); and (ii) technical data, trade secrets, know-how, research, product or service ideas or plans, software codes and
designs, algorithms, developments, inventions, patent applications, laboratory and process notebooks, processes, formulas and formulations
, techniques, device fabrication and materials, mask works, engineering and process designs and drawings, hardware and process
configuration information, agreements with third parties, lists of, or information relating to, employees and consultants of the
Company (including, but not limited to, the names, contact information, jobs, compensation, and expertise of such employees and
consultants), lists of, or information relating to, suppliers and customers (including, but not limited to, customers of the Company
on whom the Assigned Consultant called or with whom Assigned Consultant became acquainted during the Consulting Relationship),
price lists, pricing methodologies, cost data, market share data, marketing plans, licenses, contract information, business plans,
financial modeling and forecasts, historical financial data, budgets or other business or technology information disclosed to VAMI
or the Assigned Consultant by the Company either directly or indirectly, whether in writing, electronically, orally, or by observation.

 

6.2.3       Third
Party Information. VAMI and the Assigned Consultant’s agreements in this Section 6.2 are intended to be for
the benefit of the Company and any third party that has entrusted information or physical material to the Company in confidence.
During the term of the Consulting Relationship and thereafter, the Assigned Consultant will not improperly use or disclose to the
Company any confidential, proprietary or secret information of VAMI or the Assigned Consultant’s former clients or any other
person, and neither VAMI nor the Assigned Consultant will bring any such information onto the Company’s property or place
of business or incorporate any such confidential, proprietary or secret information in connection with the Services.

 

6.2.4       Other
Rights. This Agreement is intended to supplement, and not to supersede, any rights the Company may have in law or equity
with respect to the protection of trade secrets or confidential or proprietary information, including, but not limited to any rights
set forth in the Prior Agreement, which by their terms survive termination.

 

6.2.5       U.S.
Defend Trade Secrets Act. Notwithstanding the foregoing, the U.S. Defend Trade Secrets Act of 2016 (“DTSA”)
provides that an individual shall not be held criminally or civilly liable under any federal or state trade secret law for the
disclosure of a trade secret that is made (i) in confidence to a federal, state, or local government official, either directly
or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or
(iii) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. In addition,
DTSA provides that an individual who files a lawsuit for retaliation by an employer for reporting a suspected violation of law
may disclose the trade secret to the attorney of the individual and use the trade secret information in the court proceeding, if
the individual (A) files any document containing the trade secret under seal; and (B) does not disclose the trade secret, except
pursuant to court order. See Exhibit 5.2 (e).

 

    	 	7	 

     

    

 

6.3       Ownership
of Inventions.

 

6.3.1       Work
for Hire. VAMI and the Assigned Consultant understand and agree that, to the extent permitted by law, all work, papers, reports,
documentation, drawings, images, product ideas, service ideas, photographs, negatives, tapes and masters therefor, computer programs
including their source code and object code, prototypes and other materials (collectively, “Work Product”),
including, without limitation, any and all such Work Product generated and maintained on any form of electronic media, that VAMI
or the Assigned Consultant generates, either alone or jointly with others, during employment with Company will be considered a
“work made for hire,” and ownership of any and all copyrights in any and all such Work Product will belong to Company.
In the event that any portion of the Work Product should be deemed not to be a “work made for hire” for any reason,
each of VAMI and the Assigned Consultant hereby assigns, conveys, transfers and grants, and agrees to assign, convey, transfer
and grant to Company all of their respective right, title, and interest in and to the Work Product and any copyright therein, and
agrees to cooperate with Company in the execution of appropriate instruments assigning and evidencing such ownership rights. rights
hereunder. Each of VAMI and the Assigned Consultant hereby waives any claim or right under “droit moral” or moral rights
to object to Company’s copyright in or use of the Work Product. Any Work Product not generally known to the public shall
be deemed Confidential Information and shall be subject to the use and disclosure restrictions herein.

 

6.3.2       Inventions.
Each of VAMI and the Assigned Consultant understand that “Inventions” means discoveries, developments, concepts,
designs, ideas, know how, modifications, improvements, derivative works, inventions, trade secrets and/or original works of authorship,
whether or not patentable, copyrightable or otherwise legally protectable. VAMI or the Assigned Consultant understands this includes,
but is not limited to, any new product, machine or process, article of manufacture, technology or process related materials, method,
procedure, process, technique, use, equipment, device, apparatus, system, compound, formulation, synthesis, composition of matter
or structure, design or configuration of any kind, or any improvement thereon. Each of VAMI and the Assigned Consultant understand
that “Company Inventions” means any and all Inventions that Each of VAMI and the Assigned Consultant, or VAMI’s
personnel or consultants may solely or jointly author, discover, develop, conceive, or reduce to practice in connection with, or
as a result of, the Services performed for the Company or otherwise in connection with the Consulting Relationship, except as otherwise
provided in Section 6.4 below.

 

6.3.3       Prior
Inventions. To preclude any possible uncertainty with respect to Inventions, VAMI shall deliver, and cause the Assigned Consultant
to deliver, within 30 calendar days of the Effective Date, a schedule (the “Prior Inventions Schedule”) setting
forth a complete list of all prior inventions, discoveries, improvements, or works of authorship that VAMI or the Assigned Consultant
has, alone or jointly with others, conceived, developed or reduced to practice or caused to be conceived, developed or reduced
to practice prior to the commencement of the Assigned Consultant ’s employment with the Company, that the Assigned Consultant
considers to be Consultant ’s property or the property of third parties and that VAMI or the Assigned Consultant wishes to
have excluded from the scope of this Agreement (collectively referred to as “Prior Inventions”). If disclosure
of any such Prior Invention would cause VAMI or the Assigned Consultant to violate any prior confidentiality agreement, the Assigned
Consultant understands that the Assigned Consultant is not to list such Prior Inventions in such attachment but is only to disclose
a cursory name for each such invention, a listing of the party(ies) to whom it belongs and the fact that full disclosure as to
such inventions has not been made for that reason. If no such disclosure is attached, Consultant
represents and warrants that there are no Prior Inventions. If, in the course of the Assigned Consultant ’s engagement
by the Company, VAMI or the Assigned Consultant incorporates a Prior Invention into a Company product, process or machine, the
Company is hereby granted and shall have a nonexclusive, royalty-free, irrevocable, perpetual, worldwide license (with rights to
sublicense through multiple tiers of sublicensees) to make, have made, modify, use and sell such Prior Invention. Notwithstanding
the foregoing, VAMI or the Assigned Consultant agree that neither VAMI nor the Assigned Consultant will incorporate, or permit
to be incorporated, Prior Inventions in any Company inventions without the Company’s prior written consent.

 

    	 	8	 

     

    

 

6.3.4Use
or Incorporation of Inventions. If VAMI or the Assigned Consultant incorporates any Inventions relating in any way to the Company’s
business or demonstrably anticipated research or development that were conceived, reduced to practice, created, derived, developed
or made by VAMI or the Assigned Consultant either outside the scope of VAMI or the Assigned Consultant’s Services for the
Company under this Agreement or prior to the execution of this Agreement (collectively, the “Out-of-Scope Inventions”)
into any of the Company Inventions, each of VAMI and the Assigned Consultant hereby grants to the Company a royalty-free, irrevocable,
worldwide, fully paid-up license (with rights to sublicense through multiple tiers of sublicensees) to practice all applicable
patent, copyright, moral right, mask work, Trade Secret and other intellectual property rights or know-how relating to any Out-of-Scope
Inventions that Consultant incorporates, or permits to be incorporated, in any Company Inventions. VAMI and the Assigned Consultant
agree that neither VAMI nor the Assigned Consultant will not incorporate, or permit to be incorporated, any Inventions or know-how
conceived, reduced to practice, created, derived, developed or made by others or any Out-of-Scope Inventions into any Company Inventions
without the Company’s prior written consent.

 

6.3.5       Assignment
of Company Inventions. The VAMI and the Assigned Consultant, as the case may be, will
promptly make full written disclosure to the Company, will hold in trust for the sole right and benefit of the Company, and hereby
assigns to the Company, or its designee, all of the VAMI or the Assigned Consultant’s,
as the case may be, right, title and interest throughout the world in and to any and all Company Inventions and all patent, copyright,
trademark, trade secret and other intellectual property rights and other proprietary rights therein. VAMI and the Assigned
Consultant hereby waive and irrevocably quitclaim to the Company or its designee any and all claims,
of any nature whatsoever, that VAMI and the Assigned Consultant now has or may hereafter have
for infringement of any and all Company Inventions. Any assignment of Company Inventions includes all rights of attribution, paternity,
integrity, modification, disclosure and withdrawal, and any other rights throughout the world that may be known as or referred
to as “moral rights,” “artist’s rights,” “droit moral,” or the like (collectively, “Moral
Rights”). To the extent that Moral Rights cannot be assigned under applicable law, Consultant hereby waives and agrees
not to enforce any and all Moral Rights, including, without limitation, any limitation on subsequent modification, to the extent
permitted under applicable law. If VAMI or the Assigned Consultant has any rights to the Company
Inventions, other than Moral Rights, that cannot be assigned to the Company, VAMI and the Assigned Consultant,
as the case may be, hereby unconditionally and irrevocably grants to the Company during the term of such rights, an exclusive,
irrevocable, perpetual, worldwide, fully paid and royalty-free license, with rights to sublicense through multiple levels of sublicensees,
to reproduce, distribute, display, perform, prepare derivative works of and otherwise modify, make, have made, sell, offer to sell,
import, practice methods, processes and procedures and otherwise use and exploit, such Company Inventions.

 

6.3.6       Related
Rights. To the extent that VAMI or the Assigned Consultant owns or controls (presently
or in the future) any patent rights, copyright rights, mask work rights, trade secret rights, trademark rights, service mark rights,
trade dress or any other intellectual property or proprietary rights that may block or interfere with, or may otherwise be required
for, the exercise by Company of the rights assigned to Company under this Agreement (collectively, “Related Rights”),
each of VAMI and the Assigned Consultant, as applicable, hereby grants or will cause to be granted to Company a non-exclusive,
royalty-free, irrevocable, perpetual, transferable, worldwide license (with the right to sublicense) to make, have made, use, offer
to sell, sell, import, copy, modify, create derivative works based upon, distribute, sublicense, display, perform and transmit
any products, software, hardware, methods or materials of any kind that are covered by such Related Rights, to the extent necessary
to enable Company to exercise all of the rights assigned to Company under this Agreement.

 

    	 	9	 

     

    

 

6.3.7       Maintenance
of Records. Each of VAMI and the Assigned Consultant, as applicable, shall keep and maintain adequate and current written
records of all Company Inventions made or conceived by Consultant or Consultant’s personnel (solely or jointly with others)
during the term of the Consulting Relationship. The records may be in the form of notes, sketches, drawings, flow charts, electronic
data or recordings, laboratory and process notebooks, or any other format. The records will be available to and remain the sole
property of the Company at all times. Neither VAMI nor the Assigned Consultant shall remove such records from the Company’s
place of business or systems except as expressly permitted by Company policy which may, from time to time, be revised at the sole
election of the Company for the purpose of furthering the Company’s business. Each of VAMI and the Assigned Consultant, as
applicable, shall deliver all such records (including any copies thereof) to the Company at the time of termination of the Consulting
Relationship as provided for in Section 10.15.

 

6.3.8       Intellectual
Property Rights. Each of VAMI and the Assigned Consultant, as applicable, shall assist the Company, or its designee, at
its expense, in every proper way in securing the Company’s, or its designee’s, rights in the Company Inventions and
any copyrights, patents, trademarks, mask work rights, Moral Rights, or other intellectual property rights relating thereto in
any and all countries, including the disclosure to the Company or its designee of all pertinent information and data with respect
thereto, the execution of all applications, specifications, oaths, assignments, recordings, and all other instruments which the
Company or its designee shall deem necessary in order to apply for, obtain, maintain and transfer such rights, or if not transferable,
waive and shall never assert such rights, and in order to assign and convey to the Company or its designee, and any successors,
assigns and nominees the sole and exclusive right, title and interest in and to such Company Inventions, and any copyrights, patents,
mask work rights or other intellectual property rights relating thereto. VAMI’ or the Assigned Consultant’s obligation,
as the case may be, to execute or cause to be executed, when it is in their respective power to do so, any such instrument or papers
shall continue during and at all times after the end of the Consulting Relationship and until the expiration of the last such intellectual
property right to expire in any country of the world. Each of VAMI and the Assigned Consultant hereby irrevocably designates and
appoints the Company and its duly authorized officers and agents as their respective agent and attorney-in-fact, to act for and
in their respective behalf and stead to execute and file any such instruments and papers and to do all other lawfully permitted
acts to further the application for, prosecution, issuance, maintenance or transfer of letters patent, copyright, mask work and
other registrations related to such Company Inventions. This power of attorney is coupled with an interest and shall not be affected
by VAMI or the Assigned Consultant’s subsequent incapacity or unavailability.

 

6.4       Exception
to Assignments. Subject to the requirements of applicable state law, if any, VAMI and the Assigned Consultant understands that
the Company Inventions will not include, and the provisions of this Agreement requiring assignment of Inventions to the Company
do not apply to, any invention which qualifies fully for exclusion under the provisions of applicable law, if any. Generally, such
laws, exclude any inventions, discoveries, trade secrets and improvements, whether or not patentable, that Consultant has developed
entirely on its or his own time without using the Company's equipment, supplies, facilities, trade secret information or Confidential
Information except for those inventions that either (i) relate at the time of conception or reduction to practice of the invention
to the Company's business, or actual or demonstrably anticipated research or development of the Company or (ii) result from any
work that was performed for the Company. VAMI and the Assigned Consultant will advise the Company promptly in writing of any inventions
that it believes meet the foregoing criteria and not otherwise disclosed on Exhibit 6.3.3.

 

    	 	10	 

     

    

 

In order to assist
in the determination of which inventions qualify for such exclusion, Consultant will advise the Company promptly in writing, during
and for a period of twelve (12) months immediately following the termination of the Consulting Relationship, of all Inventions
solely or jointly conceived or developed or reduced to practice by VAMI and the Assigned Consultant or VAMI’s personnel in
connection with, or as a result of, the Services performed for the Company during the Term (and any extension thereof).

 

7.       Non-Disparagement.
During the Consulting Term and at all times thereafter, neither VAMI nor the Assigned Consultant shall make any derogatory comment
concerning the Company or any of its current or former directors, officers, stockholders or employees.  Similarly, the then
current (i) members of the Board and (ii) members of the Company's senior management shall not make any derogatory comment concerning
VAMI and the Assigned Consultant. Notwithstanding anything to the contrary herein, VAMI and the Assigned Consultant understands
that nothing in this Agreement restricts or prohibits VAMI and the Assigned Consultant from initiating communications directly
with, responding to any inquiries from, providing testimony before, providing confidential information to, reporting possible violations
of law or regulation to, or from filing a claim or assisting with an investigation directly with a self-regulatory authority or
a government agency or entity, or from making other disclosures that are protected under the whistleblower provisions of state
or federal law or regulation, and pursuant to 18 USC § 1833(b), an individual may not be held liable under any criminal or
civil federal or state trade secret law for disclosure of a trade secret: (i) made in confidence to a government official, either
directly or indirectly, or to an attorney, solely for the purpose of reporting or investigating a suspected violation of law or
(ii) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  Additionally,
an individual suing an entity for retaliation based on the reporting of a suspected violation of law may disclose a trade secret
to the individual's attorney and use the trade secret information in the court proceeding, so long as any document containing the
trade secret is filed under seal and the individual does not disclose the trade secret except pursuant to court order.  Nothing
in this Agreement is intended to conflict with 18 USC § 1833(b) or create liability for disclosures of trade secrets that
are expressly allowed by 18 USC § 1833(b).

 

8.       Cooperation.
During and after the Consulting Term, VAMI and the Assigned Consultant shall cooperate fully with the Company in the defense or
prosecution of any claims or actions now in existence or which may be brought in the future against or on behalf of the Company
which relate to events or occurrences that transpired during anytime in which the VAMI and Assigned Consultant were engaged by
the Company. The Company shall fairly compensate VAMI and for the time of the Assigned Consultant and shall reimburse it for any
reasonable out-of-pocket expenses incurred in connection with the Assigned Consultant’s performance of obligations pursuant
to this Section 8. The Assigned Consultant’s full cooperation in connection with such claims or actions shall
include, but not be limited to, being available to meet with counsel to prepare for discovery or trial and to act as a witness
for the Company at mutually convenient times.

 

9.       Non-Competition. Non-Competition
and Non-Solicitation and Non-Circumvention.

 

9.1        Non-Competition.Except
as authorized by the Company, during the Consulting Term and for a period of twelve (12) months thereafter, neither VAMI nor the
Assigned Consultant will (except as an officer, director, stockholder, employee, agent or consultant of the Company or any subsidiary
or affiliate thereof) either directly or indirectly, whether or not for consideration, (i) in any way, directly or indirectly,
solicit, divert, or take away the business of any person who is or was a customer of the Company, or in any manner influence such
person to cease doing business in part or in whole with Company; (ii) engage in a Competing Business; or (iii) except for investments
or ownership in public entities, mutual funds and similar investments, none of which constitute more than 5% of the ownership (provided
such ownership interest is acquired solely for investment purposes) or control of such entities, own, operate, control, finance,
manage, advise, be employed by or engaged by, perform any services for, invest or otherwise become associated in any capacity with
any person engaged in a Competing Business; or (iv) engage in any practice the purpose or effect of which is to intentionally evade
the provisions of this covenant. For purposes of this section, “Competing Business” means any company or business
which is engaged directly or indirectly in any Company Business carried on or planned to be carried on (if such plans were developed
the term of the Consulting Relationship) by the Company; and “Company Business” means the Company’s business
activities and operations as conducted during the term of the Consulting Relationship and all products conceived, planned, researched,
developed, tested, manufactured, sold, licensed, leased or otherwise distributed or put into use by the Company, together with
all services provided or planned by the Company, during your Consulting Relationship with the Company.

 

    	 	11	 

     

    

 

9.2       Non-Solicitation
and Non-Circumvention. For a period of twelve (12) months following the termination of the Consulting Term, neither VAMI nor
the Assigned Consultant will directly or indirectly, whether for your account or for the account of any other individual or entity,
solicit or canvas the trade, business or patronage of, or sell to, any individuals or entities that were investors, customers or
employees of the Company during the Consulting Term, or prospective customers with respect to whom a sales effort, presentation
or proposal was made by the Company or its affiliates, during the one year period prior to the termination of the Consulting Term.
Without limiting the foregoing, Consultant shall not, directly or indirectly (i) solicit, induce, enter into any agreement with,
or attempt to influence any individual who was an employee or consultant of the Company at any time during the Consulting Term,
to terminate its, her or his relationship with the Company or to become employed or engaged by VAMI or any individual or entity
by which Consultant may be engaged or for which it is acting as a consultant or advisor, and/or (ii) interfere in any other way
with the employment, or other relationship, of any employee of, or consultant to, the Company.

 

9.3       
Injunctive Relief.  VAMI and the Assigned Consultant acknowledges and agrees that the covenants and obligations of
Consultant set forth in this Agreement relate to special, unique and extraordinary Services rendered by VAMI and the Assigned Consultant
to the Company and that a violation of any of the terms of such covenants and obligations will cause the Company irreparable injury
for which adequate remedies are not available at law.  Therefore, Consultant agrees that the Company shall be entitled to
seek an injunction, restraining order or other temporary or permanent equitable relief (without the requirement to post bond) restraining
VAMI and the Assigned Consultant from committing any violation of the covenants and obligations contained herein.  These injunctive
remedies are cumulative and are in addition to any other rights and remedies the Company may have at law or in equity.

 

10.       Miscellaneous.

 

10.1        Assignment.
Neither this Agreement nor any right or interest hereunder shall be assignable by VAMI or the Assigned Consultant. This Agreement
may be assigned by the Company without the consent of VAMI or the Assigned Consultant to a person or entity which is an affiliate
or a successor in interest (by law or agreement) to substantially all of the assets or business operations of the Company. Upon
any such assignment, the rights and obligations of the Company hereunder shall become the rights and obligations of such affiliate
or successor person or entity.

 

10.2       Code
of Ethics.  VAMI and the Assigned Consultant acknowledge receipt of the Company’s “Code of Corporate Governance
and Ethics,” and having read the same agree to abide by the terms thereof.

 

    	 	12	 

     

    

 

10.3       Entire
Agreement.

 

10.3.1 This Agreement
contain the entire understanding of the Parties with respect to the engagement of VAMI and the Assigned Consultant by the Company
and supersede any prior agreements between the Parties (including the Prior Agreement”) relating to the subject matter herein,
which agreements, are hereby mutually terminated and cancelled. Anything in the foregoing to the contrary notwithstanding, those
provisions of the Prior Agreement that were to survive the termination thereof shall remain in full force and effect in accordance
with their terms.

 

10.3.2 There are no restrictions,
agreements, promises, warranties, covenants or undertakings between the parties with respect to the subject matter herein other
than those expressly set forth herein or in the Confidentiality Agreement. This Agreement may not be altered, modified, or amended
except by written instrument signed by the parties hereto.

 

10.4       Severability.
If one or more provisions of this Agreement are held to be unenforceable under applicable law, the parties agree to renegotiate
such provision in good faith. In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such
provision, then (i) such provision shall be excluded from this Agreement, (ii) the balance of the Agreement shall be
interpreted as if such provision were so excluded and (iii) the balance of the Agreement shall be enforceable in accordance
with its terms.

 

10.5       Waiver;
Amendment.

 

10.5.1 No term or condition
of this Agreement shall be deemed to have been waived, nor shall there be an estoppel against the enforcement of any provision
of this Agreement, except by written instrument of the Party charged with such waiver or estoppel. No such written waiver shall
be deemed a continuing waiver, unless specifically stated therein, and each waiver shall operate only as to the specific term or
condition waived and shall not constitute a waiver of such term or condition for the future or as to any act other than the act
specifically waived.

 

10.5.2 This Agreement
may be amended or modified only by mutual agreement of duly authorized representatives of the parties in writing.

 

10.6       Acknowledgment
as to Legal Counsel. VAMI and the Assigned Consultant each acknowledges that they have had the opportunity to consult legal
counsel and a tax advisor in regard to this Agreement, and that they have read and understand this Agreement. Each of VAMI and
the Assigned Consultant is fully aware of the legal effect of this Agreement and has entered into it freely and voluntarily and
based on its or his own judgment and not based on any representations or promises other than those contained herein.

 

10.7       
Representations of Consultant; Absence of Conflicts. Each of VAMI and
the Assigned Consultant represent and warrant to the Company that (i) each is entering into this Agreement voluntarily and that
the engagement hereunder and compliance with the terms and conditions hereof will not conflict with or result in the breach by
either VAMI or the Assigned Consultant of any agreement to which either is a party or by which either may be bound, (ii) the engagement
by the Company of VAMI and the Assigned Consultant, does not, and will not, violate any non-competition, non-solicitation or other
similar covenant or agreement by which either is or may be bound, (iii) neither VAMI nor the Assigned Consultant has any outstanding
commitments inconsistent with any of the terms of this Agreement or the Services to be rendered hereunder, and (iv) in connection
within this engagement with the Company neither will use any confidential or proprietary information that may have obtained in
connection with said engagement with any prior or future employer.

 

    	 	13	 

     

    

 

10.8       Notices.
Any notice or other communication required or permitted pursuant to this Agreement shall be in writing and addressed as follows:

 

If to the Company:

 

SolarWindow Technologies, Inc.

300 Main Street

Suite 6

Vestal, New York 13850

Attention: Harmel S. Rayat, Chairman
of the Board

Email: hsr@solarwindow.com

 

 

If to VAMI or the Assigned Consultant:

 

Vector Asset
Management, Inc.

700 - 688 West Hastings Street

Vancouver, BC V6B 1P1

Attention: President & CEO

JSBhogal@vectorasset.com

 

 

or, to such other address or facsimile
number as any Party shall have furnished to the other in writing in accordance with this Section 18.

 

Notices sent in accordance with this Section
shall be deemed effectively given: (a) when received, if delivered by hand (with written confirmation of receipt); (b) when received,
if sent by a nationally recognized overnight courier (receipt requested); (c) on the date sent by facsimile or e-mail (in each
case, with confirmation of transmission), if sent during normal business hours of the recipient, and on the next Business Day if
sent after normal business hours of the recipient; or (d) on the third (3rd) Business Day after the date mailed, by certified or
registered mail, return receipt requested, postage prepaid.

 

10.9       Currency.
Unless otherwise stipulated, all payments required to be made pursuant to the provisions of this Agreement and all money amount
references contained herein or in any exhibit or schedule hereto are in lawful currency of the United States.

 

10. 10    Surviving
Provisions. Notwithstanding the termination of this Agreement and the Consulting Relationship, the rights and obligations contained
in this Agreement, including without limitation Sections 5, 6, 7, 8, 9 and 10, which by their nature require performance
following termination, shall survive any termination or expiration of this Agreement the terms and conditions set forth in of this
Agreement shall survive any termination of this Agreement.

 

10.11       Execution
by All Parties; Counterparts; Delivery by Email or Facsimile.

 

    	 	14	 

     

    

 

10.11.1 This Agreement
shall not be binding or enforceable unless and until executed on behalf of all parties hereto.

 

10.11.2 This Agreement
may be executed in one or more counterparts, all of which shall be considered one and the same agreement, and shall become effective
when one or more counterparts have been signed by the Company, VAMI and the Assigned Consultant and delivered to the other, it
being understood that the Company and Consultant need not sign the same counterpart. This Agreement may be executed by facsimile
or email signature and a facsimile or email signature shall constitute an original for all purposes.

 

10.11.3 This Agreement,
the agreements referred to herein, and each other agreement or instrument entered into in connection herewith or therewith or contemplated
hereby or thereby, and any amendments hereto or thereto, to the extent signed and delivered by means of a facsimile machine or
email, shall be treated in all manner and respects as an original agreement or instrument and shall be considered to have the same
binding legal effect as if it were the original signed version thereof delivered in person. At the request of a Party hereto or
to any such agreement or instrument, each other Party hereto or thereto shall re-execute original forms thereof and deliver them
to all other parties. No Party hereto or to any such agreement or instrument shall raise the use of a facsimile machine or email
to deliver a signature or the fact that any signature or agreement or instrument was transmitted or communicated through the use
of a facsimile machine or email as a defense to the formation or enforceability of a contract and each such Party forever waives
any such defense.

 

10.12       Construction.
The Company, VAMI and the Assigned Consultant have participated jointly in the negotiation and drafting of this Agreement. In the
event an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the
Company, VAMI and the Assigned Consultant and no presumption or burden of proof shall arise favoring or disfavoring any party by
virtue of the authorship of any of the provisions of this Agreement.

 

10.13       
Interpretation.

 

10.13.1 For purposes
of this Agreement, (a) the words “include,” “includes,” and “including” shall be deemed to
be followed by the words “without limitation;” (b) the word “or” is not exclusive; and (c) the words “herein,”
“hereof,” “hereby,” “hereto,” and “hereunder” refer to this Agreement as a whole.
Unless the context otherwise requires, references herein: (x) to Sections, Exhibits and Schedules refer to the Sections of, and
Exhibits and Schedules attached to, this Agreement; (y) to an agreement, instrument, or other document means such agreement, instrument,
or other document as amended, supplemented, and modified from time to time to the extent permitted by the provisions thereof; and
(z) to a statute means such statute as amended from time to time and includes any successor legislation thereto and any regulations
promulgated thereunder. Any Exhibits or Schedules referred to herein shall be construed with, and as an integral part of,
this Agreement to the same extent as if they were set forth verbatim herein.

 

10.13.2 Any reference
to any federal, state, local, or foreign statute or law shall be deemed also to refer to all rules and regulations promulgated
thereunder, unless the context requires otherwise. The word “including” shall mean including without limitation. Whenever
the context may require, any pronouns used in this Agreement shall include the corresponding masculine, feminine or neuter forms,
and the singular forms of nouns and pronouns shall include the plural, and vice versa. The headings in this Agreement are solely
for the convenience of reference and shall be given no effect in the construction or interpretation of this Agreement. Section
references are to sections of this Agreement unless otherwise specified. Any reference herein to “Consultant”
shall mean both VAMI and the Assigned Consultant.

 

    	 	15	 

     

    

 

10.14        Indemnification.

 

10.14.1 Indemnification
of Consultant by the Company. The Company shall indemnify, defend and hold Consultant its subsidiaries, affiliates, officers,
directors and employees harmless from and against any and all liabilities, obligations, losses, claims, damages, costs, charges
or other expenses of any kind (including, but not limited to, reasonable attorneys’ fees and legal costs) (collectively,
“Claims”) which arise out of or result from any breach or alleged breach of this Agreement by the Company. The
Assigned Consultant shall be covered by any directors and officers insurance policies (the “D&O Insurance”),
with such indemnification to be on terms determined by the Board or any of its committees, but on terms no less favorable than
provided to any other Company executive officer or director and subject to the terms of any separate written indemnification agreement.

 

10.14.2 Indemnification
of Company by Consultant. Each of VAMI and the Assigned Consultant, jointly and severally, shall indemnify, defend and
hold harmless the Company, its subsidiaries, affiliates, officers, directors and employees, from and against any and all Claims
which arise out of, or result from, any breach or alleged breach of this Agreement by Consultant or any claim arising out of Consultant’s
negligence or wanton or willful misconduct in the performance of its obligations under this Agreement.

 

 

10.15   Ownership
and Return of Company Property. All materials furnished to Consultant by the Company, including Confidential Information,
whether delivered to Consultant by the Company or made by Consultant in the performance of services under this Agreement (collectively,
the “Company Property”) are the sole and exclusive property of the Company, and Consultant hereby does and will
assign to the Company all rights, title and interest Consultant may have or acquire in the Company Property. At the Company’s
request and no later than five (5) days after such request, Consultant shall, at the Company’s option, destroy or deliver
to the Company (i) all Company Property, (ii) all tangible media of expression in Consultant’s possession or control that
incorporate or in which are fixed any Confidential Information of the Company, and (iii) written certification of Consultant’s
compliance with Consultant’s obligations under this Agreement.

 

10.16       Equitable
Remedies.  Each Party hereto acknowledges that the other Parties hereto would be irreparably damaged in the event of a
breach or threatened breach by such Party of any of its obligations under this Agreement and hereby agrees that in the event of
a breach or a threatened breach by such Party of any such obligations, each of the other Parties hereto shall, in addition to any
and all other rights and remedies that may be available to them in respect of such breach, be entitled to an injunction from a
court of competent jurisdiction (without any requirement to post bond) granting such parties specific performance by such Party
of its obligations under this Agreement. In the event that any party files a suit to enforce the covenants contained in this Agreement
or obtain any other remedy in respect of any breach thereof), the prevailing Party in the suit shall be entitled to receive in
addition to all other damages to which it may be entitled, the costs incurred by such party in conduction the suit, including reasonable
attorney’s fees and expenses.

 

    	 	16	 

     

    

 

10.17       Governing
Law. Any term or provision of this Agreement that is invalid or unenforceable for any reason whatsoever that provision
shall be divisible from this Agreement and shall be deemed to be deleted from it and the validity of the remaining provisions shall
not be affected. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be
governed by the internal laws of the State of Nevada without giving effect to any choice of law or conflict of law provision or
rule (whether of the State of Nevada or any other jurisdictions) that would cause the application of the laws of any jurisdictions
other than the State of Nevada. In the event of any action being commenced hereunder, each Party hereby irrevocably submits to
the exclusive jurisdiction of the state and federal courts sitting in the State of New York, City of New York, County of New York,
for the adjudication of any dispute hereunder or in connection herewith or therewith, or with any transaction contemplated hereby
or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that
it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient
forum or that the venue of such suit, action or proceeding is improper. Each Party hereby irrevocably waives personal service of
process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such Party at
the address for such notices to it under this Agreement and agrees that such service shall constitute good and sufficient service
of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner
permitted by law. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION
OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

[SIGNATURES APPEAR ON THE FOLLOWING PAGE

 

 

 

 

 

 

 

    	 	17	 

     

    

 

IN WITNESS WHEREOF,
the parties have duly executed this Agreement on the dates set forth below to be effective as of the Effective Date.

 

	
         

        VECTOR ASSET MANAGEMENT, INC.
	 
	 	 
	 	 
	 	 
	 	 
	By:	__________________________________________	Dated: June 29, 2020
	Name:	Jatinder S. Bhogal	 
	Title:	President	 
	 	 	 
	 	 	 
	ASSIGNED CONSULTANT	 
	 	 
	 	 
	 	 
	 	 
	 	__________________________________________	Dated: June 29, 2020
	Name:	Jatinder S. Bhogal	 
	 	 
	 	 
	SOLARWINDOW TECHNOLOGIES, INC.	 
	 	 
	 	 
	 	 
	 	 
	By:	__________________________________________	Dated: June 29, 2020
	Name: 	Harmel S. Rayat	 
	Title:	Chairman of the Board, Authorized Signatory	 

 

 

 

    	 	18	 

     

    

 

EXHIBIT 2.2

TO THE CONSULTING AGREEMENT DATED JUNE
29, 2020

BY AND AMONG 

SOLARWINDOW TECHNOLOGIES, INC., 

VECTOR ASSET MANAGEMENT, INC.

AND

JATINDER S. BHOGAL

(THE “CONSULTING AGREEMENT”)

 

*****

 

OUTSIDE SERVICE CAPACITIES 

 

Capitalized terms used in this Exhibit 2.2 and not otherwise
defined shall have the meaning ascribed thereto in the Consulting Agreement.

 

 

VAMI and the Assigned Consultant as of July 1, 2020 provide,
and anticipate continuing to provide, during the Consulting Term, consulting services to the following entities:

 

RenovaCare, Inc.

 

StemCell Systems GmbH

 

GlobalOne Sciences Corp.

 

RevyvLife Sciences Inc.

 

MicroTransplant Technologies

 

Cosmic Medical

 

 

 

 

 

    	 	19	 

     

    

 

EXHIBIT 3.1

TO THE CONSULTING AGREEMENT DATED JUNE
29, 2020

BY AND AMONG

SOLARWINDOW TECHNOLOGIES, INC.,

VECTOR ASSET MANAGEMENT, INC.

AND

JATINDER S. BHOGAL

(THE “CONSULTING AGREEMENT”)

*****

 

COMPENSATION RIDER

 

Capitalized terms used in this Exhibit
3.1 and not otherwise defined shall have the meaning ascribed thereto in the Consulting Agreement.

 

1.        Annual Base
Consulting Fee

 

(a) During the Initial
Term, in consideration of the Services to be provided, inclusive of those provided by the Company shall pay VAMI an annual base
consulting fee of $410,000 (the “Base Annual Consulting Fee”) payable in accordance with the Company’s
general payroll policies.

 

(b) Not less than
yearly, the Board shall evaluate the Base Annual Consulting Fee in light of the performance of Consultant and the Company and in
its discretion increase such fee as the Board deems appropriate.

 

2.       Discretionary
Annual Performance Bonus

 

(a)       During
the Consulting Term, in the sole discretion of the Board, following each calendar year of employment, the Employee may be eligible
to receive a discretionary cash bonus, of up to forty percent (40%) of the Employee’s Base Salary (the “Discretionary
Annual Performance Bonus”), based on Consultant’s achievement relative to certain performance goals (“Performance
Goals”) to be established by the Board. The determination of whether Consultant has met the Performance Goals for any
given year, and if so, the amount of any Discretionary Annual Performance Bonus that will be paid for such year, if any, shall
be determined by the Board in its sole and absolute discretion. In order to be eligible to earn or receive any Discretionary Annual
Bonus the Consulting Relationship must remain effective through and including the end of the year with respect to which such Discretionary
Annual Performance Bonus is awarded and earned. Any awarded Discretionary Annual Performance Bonus will be paid no later than March
15th of the calendar year immediately following the calendar year with respect to which the Discretionary Annual Bonus was awarded
(the “Bonus Payment Date”). Any bonus with respect to the 2020 calendar year, if any, will be prorated to reflect
the period during which the Employee was employed.

 

(b)       Notwithstanding
the foregoing, if the Company (A) terminates the Consulting Agreement without Cause pursuant to Section 4.4 or (B)
in the event that the Consulting Agreement is terminated pursuant to Section 4.1 as a result of the Employee’s death
or Permanent Disability (as defined in, and pursuant to Section 4.2), in any case prior to the last day of the calendar
year with respect to which the Discretionary Annual Performance Bonus is to be paid, VAMI may receive, at the discretion of the
Board, a prorated portion of any Discretionary Annual Performance Bonus, that the Board, in its sole discretion, may award (prorated,
as to any such calendar year, through the date of such termination), which prorated portion shall be paid in any case on the Bonus
Payment Date (the “Prorated Performance Bonus Payment”).

 

    	 	20	 

     

    

 

3.        Stock Option
Award

 

(a)       2020 Option
Grant: The Company granted VAMI a conditional non-statutory stock option on June 8, 2020 (the “Stock Option”) having
the terms set forth below. The Stock Option was subject to the execution of and delivery of a definitive employment agreement which
condition has been satisfied and the Stock Option shall be effective as of the Effect Date of the Consulting Agreement. The Stock
Option granted VAMI the right to purchase 2,500,000 shares of common stock of the Company, par value $0.0001 per share (“Common
Stock”) at a purchase price of $2.60 per share, the closing price of the Company’s common stock on June 8, 2020.
The Stock Option has a six-year term, and subject to the terms and conditions of the Stock Option Grant and Grant Agreement dated
June 29, 2020 and effective July 1, 2020 (the “Grant Agreement”), vests and is exercisable at the prices set
forth in the table below.

 

	Vesting Date	Number of Shares Vesting	Initial Exercise Price
	July 1 2020*	1,250,000	$2.60**
	June 30, 2021***	1,250,000	$2.60**

 *
The Effective Date of the Consulting Agreement; and

** Closing price of the Common
Stock on June 8, 2020, the date of grant. 

***One day before the 1st
anniversary date of the Effective Date of the Consulting Agreement.

 

In the event that,
following a Change of Control (as defined in the Grant Agreement), the Company Relationship is terminated on or prior to the 1st
anniversary of Effective Date, then all unvested stock option hereunder, regardless of date or condition of vesting, shall vest
as of the date of such termination. If, upon the Change of Control, (i) the Company shall cease to be a stand-alone publicly
traded entity, or (ii) the acquiring entity is unwilling to assume the equity in an economically equivalent manner, then in
either event, all equity shall be deemed to have vested two (2) days prior to the Change of Control, but only if such Change
of Control shall actually be consummated.

 

The exercise price
of the Stock Option shall be paid:

 

(i) in cash or
by certified check or bank draft payable to the order of the Company;

 

(ii) by delivering,
along with a properly executed exercise notice to the Company, a copy of irrevocable instructions to a broker to deliver promptly
to the Company the aggregate exercise price and, if requested by the Optionee, the amount of any applicable federal, state, local
or foreign withholding taxes required to be withheld by the Company, provided, however, that such exercise may be implemented solely
under a program or arrangement established and approved by the Company with a brokerage firm selected by the Company;

 

(iii) at any time
prior to the Company’s listing of any of its securities for trading on a national stock exchange, pursuant to “a net
issue” or “cashless” exercise basis; or

 

(iv) by any other procedure approved by the
Board or its Compensation Committee, if any, or by a combination of the foregoing.

 

(b)       Pursuant
to the terms of the Consulting Agreement VAMI has assigned and transferred the 2020 Option Grant to the Assigned Consultant and
has directed the Company to issue the option directly to and in the name of the Assigned Consultant.

 

    	 	21	 

     

    

 

(c)       The
Board in its discretion may during the Consulting Term grant such additional equity awards to VAMI as it deems appropriate.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

22Exhibit 10.2

 

 

Stock
Option Grant and Grant Agreement

Pursuant
to The 

SolarWindow
Technologies, Inc. 2006 Incentive Stock Option Plan

 

This Stock Option Grant
and Grant Agreement dated as of June 29, 2020 between SolarWindow Technologies, Inc., a Nevada Corporation having an office at
300 Main Street Suite 6, Vestal, New York 13850 (the “Company”), and Jatinder S. Bhogal (the “Optionee”).
The effective date of this Agreement is July 1, 2020.

 

On June 8, 2020, the
Optionee, a director of the Company, and the Company entered into a Memorandum of Understanding outlining the general terms and
conditions of a proposed consulting arrangement between the Company and Vector Asset Management, Inc., a Canadian corporation wholly-owned
by the Optionee (“VAMI”); among the terms was a condition that the Company grant a provisional stock option
to VAMI the effectiveness of which was conditioned upon the negotiation, execution and delivery of a definitive consulting agreement
no later than June 30, 2020 (the “Conditional Option Grant”).

 

Pursuant to the Conditional
Grant, the Optionee has the right, but not the obligation, to purchase up to 2,500,000 shares of the Company’s common stock
at a per share purchase price of $2.60, the closing price of the Company’s common stock on the OTC Markets Pink Sheets on
June 8, 2020 (the “Conditional Option Grant Date”)

 

The Optionee, VAMI
and the Company signed and delivered an Executive Services Consulting Agreement on June 29, 2020, and effective as of July 1, 2020
(the “Consulting Agreement”), pursuant to which and at the direction of VAMI, the Optionee will (i) provide
executive consulting services to the Company and assume the title of, and have the duties and responsibilities associated with,
the Company’s President and Chief Executive Officer and continue to serve on the Company’s Board of Directors (collectively,
the “Company Relationship”).

 

The Conditional Option
Grant became effective as of July 1, 2020 (the “Effective Date”) and is referred to as the “Stock Option”
in the remainder of this Agreement.

 

Pursuant to the terms
of the Consulting Agreement, VAMI assigned and transferred the Stock Option to the Optionee and directed the Company to issue the
Stock Option directly to and in the name of the Optionee.

 

The Stock Option is
a non-statutory stock option and is being issued pursuant to the Company’s 2006 Incentive Stock Plan (the “2006
Plan”).

 

The Stock Option has
a term of six (6) years; and, vesting as to 50% thereof on the Effective Date and as to the remaining 50% on June 30, 2021.

 

Accordingly, in consideration
of the mutual promises and covenants made herein and the mutual benefits to be derived here from, the parties hereto agree as follows:

 

1. Grant of Stock
Option.

 

Subject to the provisions
of this Agreement, the Consulting Agreement and the 2006 Plan the Company, hereby grants to the Optionee as of July 1, 2020 (the
“Grant Date”) the Stock Option conferring on the Optionee the right, but not the obligation, to purchase
up to 2,500,000 shares of common stock of the Company, par value $0.0001 per share (“Common Stock”), which shares
shall become vested and exercisable according to the schedule and at the exercise price set forth in Section 2 hereof. Unless
earlier terminated pursuant to the terms of this Agreement, the Stock Option shall expire on the sixth anniversary of the date
hereof. Unless otherwise specified, capitalized terms not defined herein shall have the meaning set forth in the Plan.

 

    	 	1	 

     

    

 

2. Vesting and Exercisability
of the Stock Option.

 

(a) Vesting.
Subject to the Company Relationship continuing through the dates set forth below and the other provisions of this Agreement, the
Stock Option shall vest as follows:

 

	Vesting Date	Number of Shares Vesting and as to Which This Stock Option is Exercisable	Initial Exercise Price
	July 1, 2020	1,250,000	$2.60
	June 30, 2021	1,250,000	$2.60

 

Except as otherwise specifically provided
herein, upon the termination the Company Relationship the portion of the Stock Option that is not vested as of such dates shall
cease vesting and terminate immediately.

 

(b) Acceleration
upon Change in Control. In the event that, following a Change of Control (as defined below), the Company Relationship is
terminated on or prior to the 1st anniversary of Effective Date, then all unvested stock option hereunder, regardless
of date or condition of vesting, shall vest as of the date of such termination. If, upon the Change of Control, (i) the Company
shall cease to be a stand-alone publicly traded entity, or (ii) the acquiring entity is unwilling to assume the equity in
an economically equivalent manner, then in either event, all equity shall be deemed to have vested two (2) days prior to the
Change of Control, but only if such Change of Control shall actually be consummated.

 

For the purposes this
Agreement, “Change of Control” shall mean (i) the acquisition by any individual, entity or group (within
the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)),
other than any individual, entity or group which, as of the date of this Agreement, beneficially owns more than ten percent (10%) of
the then outstanding shares of common stock of the Company (the “Common Stock”), of beneficial ownership (within
the meaning of Rule 13d-3 promulgated under the Exchange Act) of fifty percent (50%) or more of the then outstanding Common
Stock; provided, however, that any acquisition by the Company or its subsidiaries, or any employee
benefit plan (or related trust) of the Company or its subsidiaries of fifty percent (50%) or more of outstanding Common Stock
shall not constitute a Change of Control, and provided, further, that any acquisition by an entity
with respect to which, following such acquisition, more than fifty percent (50%) of the then outstanding equity interests
of such entity, is then beneficially owned, directly or indirectly, by all or substantially all of the individuals and entities
who were the beneficial owners of the outstanding Common Stock immediately prior to such acquisition of the outstanding Common
Stock, shall not constitute a Change in Control; or (ii) the consummation of a reorganization, merger or consolidation (any
of the foregoing, a “Merger”), in each case, with respect to which all or substantially all of the individuals
and entities who were the beneficial owners of the outstanding Common Stock immediately prior to such Merger do not, following
such Merger, beneficially own, directly or indirectly, more than fifty percent (50%) of the then outstanding shares of common stock
of the corporation resulting from Merger, or (iii) the sale or other disposition of all or substantially all of the assets
of the Company, excluding (a) a sale or other disposition of assets to a subsidiary of the Company; and (b) a sale or
other disposition of assets to any individual, entity or group which, as of the date of this Agreement, beneficially owns more
than ten percent (10%) of the then outstanding Common Stock.

 

    	 	2	 

     

    

 

(c) If the Company
Relationship is terminated by the Company prior to the 1st anniversary of the Grant Date without Cause, then all unvested
stock option hereunder, regardless of date or condition of vesting, shall vest as of the date of such termination. Cause for purposes
of this Grant Agreement shall mean any termination of the Company Relationship by the Company due to misconduct or unsatisfactory
performance for any of the following reasons: (i) commission and conviction of a crime against the Company, its affiliates,
customers or employees; (ii) commission and conviction of any other crime or violation of law, statute or regulation that
creates an inability to perform job duties; and (iii) breach of the terms and conditions of the Consulting Agreement which
constitute “Cause” as defined in the Consulting Agreement.

 

3. Method of Exercise
of the Stock Option.

 

(a) To the extent that
all or a portion of the Stock Option has vested, it may be exercised as to such vested amount by delivery to the Company of a written
or electronic notice, substantially in the form of Exhibit A hereto (the “Exercise Notice”), stating
the number of whole shares to be purchased pursuant to this Agreement; the Exercise Notice shall be accompanied by payment of the
full purchase price of the shares of Common Stock to be purchased. Fractional share interests, if any, shall be disregarded except
that they may be accumulated.

 

(b) The exercise price
of the Stock Option shall be paid:

 

(i) in cash or
by certified check or bank draft payable to the order of the Company;

 

(ii) by delivering,
along with a properly executed exercise notice to the Company, a copy of irrevocable instructions to a broker to deliver promptly
to the Company the aggregate exercise price and, if requested by the Optionee, the amount of any applicable federal, state, local
or foreign withholding taxes required to be withheld by the Company, provided, however, that such exercise may be implemented solely
under a program or arrangement established and approved by the Company with a brokerage firm selected by the Company;

 

(iii) at any time
prior to the Company’s listing of any of its securities for trading on a national stock exchange, pursuant to “a net
issue” or “cashless” exercise pursuant to Section 3(c) below; or,

 

(iv) by any other
procedure approved by the Board or its Compensation Committee, if any, or by a combination of the foregoing.

 

(c) Subject to the
provisions of Section 3(b) (iii) above, in lieu of exercising this Stock Option pursuant to Section 3(b) (i) and (ii)
above the Optionee may elect to receive Option Shares equal to the value of this Stock Option (or portion thereof being exercised)
by delivery of the Exercise Notice together with this Stock Option Agreement to the Company, in which event the Company shall issue
to the Optionee a number of Option Shares computed using the following formula:

 

Y (A-B)

X = ———————

A

 

    	 	3	 

     

    

 

Where:

	 	X = 	the number of the Option Shares to be issued to the Optionee;
	 	Y =	the number of the vested Option Shares purchasable under this Stock Option or if only a portion of this Stock Option is being exercise, the portion being exercised;
	 	A = 	the fair market value of one share of the Company’s common stock on the date prior to the date of exercise; and 
	 	B = 	the per share Exercise Price (as adjusted to the date of such calculation). 

 

For purposes of this Section 3(c),
the “per share fair market value” of the Option Shares shall mean:

 

(i) If the Company’s
Common Stock is publicly traded, the per share fair market value of the Warrant Shares shall be the closing price of the Common
Stock as quoted on the OTC Market Group’s Pink Sheets, or on such other exchange or trading platform on which the Company’s
Common Stock may then be listed or quoted for trading, on the trading day immediately preceding the date of exercise;

 

(ii) If the Company’s
Common Stock is not so publicly traded, the per share fair market value of the Option Shares shall be such fair market value as
is determined in good faith by the Board of Directors of the Company after taking into consideration factors it deems appropriate,
including, without limitation, recent sale and offer prices of the capital stock of the Company in private transactions negotiated
at arm’s length.

 

4. Termination of
the Company Relationship Other Than Due to Death or Disability.

 

(a) Except as provided
in (i) Section 4(b) below with regard to the Optionee’s termination of the Company Relationship for Cause or following
an event that would be grounds for a termination of the Company Relationship for Cause, and (ii) Section 5 below with regard
to the termination of the Company Relationship due to death or Disability of the Optionee, in the event of the Optionee’s
(or VAMI’s) termination of the Company Relationship, the portion of the Stock Option, if any, which is vested and exercisable
at the time of such termination may be exercised prior to the first to occur of (a) the expiration of the a two year period which
commences on the date of termination and expires on the second anniversary of such date of termination or (b) the expiration date
of the term of this Stock Option. There shall be no further vesting after the date of such termination of the Company Relationship.

 

(b) In the event of
the Optionee’s (or VAMI’s) termination of the Company Relationship for Cause (as defined in the Consulting Agreement)
or by the Company without Cause, the Optionee’s entire Stock Option (whether or not vested) shall vest and may be may be
exercised prior to the first to occur of (a) the expiration of the a two year period which commences on the date of termination
and expires on the second anniversary of such date of termination or (b) the expiration date of the term of this Stock Option.

 

(c) In the event of
the termination of the Company Relationship by the Company for Cause, all unvested and vested and unexercised options shall be
forfeited and canceled in its entirety upon the date such termination of the Company Relationship. There shall be no further vesting
after the date of such termination of the Company Relationship.

 

(d) Nothing in this
Agreement or the Plan shall confer upon the Optionee any right to continue in the service of the Company or any of its subsidiaries
or affiliates or interfere in any way with the right of the Company or any such subsidiaries or affiliates to terminate the Company
Relationship at any time, in its sole discretion.

 

    	 	4	 

     

    

 

5. Death or Disability
of Optionee. 

 

5.1In
the event of the termination of the Company Relationship due to death (or, in the event of the Optionee’s death following
termination of the Company Relationship while the Stock Option remains exercisable) the portion of the Stock Option, if any, which
is exercisable at the time of death may be exercised by the Optionee’s estate or by a person who acquired the right to exercise
such Stock Option by bequest or inheritance or otherwise by reason of the death of the Optionee at any time prior to the first
to occur of (a) the expiration of the a one year period which commences on the date of termination and expires on the first anniversary
of such date of termination or (b) the expiration date of the term of this Stock Option. There shall be no further vesting after
the date of such termination of the Company Relationship.

 

5.2 In the
event of the Optionee’s termination of the Company Relationship due to Permanent Disability (as defined below) of the Optionee,
the portion of the Stock Option, if any, which is exercisable at the time of such termination of the Company Relationship may be
exercised by the Optionee or the Optionee’s guardian or legal representative at any time prior to the first to occur of (a)
the expiration of the a one year period which commences on the date of termination and expires on the first anniversary of such
date of termination or (b) the expiration date of the term of this Stock Option. There shall be no further vesting after the date
of such termination of the Company Relationship. For purposes of this Agreement, “Permanent Disability” shall
mean the inability of the Employee to perform the essential functions of one or more of his primary duties as a result of his incapacity,
despite any reasonable accommodation required by law, due to bodily injury or disease or any other mental or physical illness,
which inability continues for a period of sixty (60) Business Days, which need not be consecutive, within any three hundred
sixty five (365) day period. A “Business Day” shall mean any day other than weekends and US federal holidays.

 

6. Non-transferability
of the Stock Option. The Stock Option is non-transferable by the Optionee other than by will or the laws of descent and distribution
or pursuant to a qualified domestic relations order, and the Stock Option may be exercised, during the lifetime of the Optionee,
only by the Optionee or by the Optionee’s guardian or legal representative or any transferee described above.

 

7. Tax Matters.

 

7.1 The Stock Option is intended to
be a Non-statutory Stock Option and shall not be treated as an incentive stock option within the meaning of Section 422(b)
of the Code. 

 

7.2 At the time
the Option is exercised, in whole or in part, or at any time thereafter as requested by the Company, the Optionee hereby authorizes
withholding from payroll and any other amounts payable to the Optionee, and otherwise agrees to make adequate provision for (including
by means of a Cashless Exercise to the extent permitted by the Company), any sums required to satisfy the federal, state, local
and foreign tax withholding obligations of the Company, if any, which arise in connection with the Option, including, without limitation,
obligations arising upon (i) the exercise, in whole or in part, of the Option, (ii) the transfer, in whole or in part,
of any shares acquired upon exercise of the Option, (iii) the operation of any law or regulation providing for the imputation
of interest, or (iv) the lapsing of any restriction with respect to any shares acquired upon exercise of the Option. The Optionee
is cautioned that the Option is not exercisable unless the tax withholding obligations of the Company are satisfied. Accordingly,
the Optionee may not be able to exercise the Option when desired even though the Option is vested, and the Company shall have no
obligation to issue a certificate for such shares or release such shares from any escrow provided for herein.

 

7.3 The
Optionee should consult with a tax advisor before exercising the Stock Option or disposing of the Shares to obtain advice as to
the consequences of such exercise or disposition.

 

    	 	5	 

     

    

 

8. Rights as a Stockholder.
An Optionee or a transferee, if any, of the Stock Option shall have no rights as a stockholder with respect to any shares covered
by such Stock Option until the date when his or her purchase is entered upon the records of the duly authorized transfer agent
of the Company. No adjustment shall be made for dividends (ordinary or extraordinary, whether in cash, securities or other property)
or distribution of other rights for which the record date is prior to the date a stock certificate is issued, except as provided
in the Plan.

 

9. Adjustment in
the Event of Change in Stock. In accordance with the 2006 Plan, in the event of any change in Corporate capitalization (including,
but not limited to, a change in the number of shares of Common Stock outstanding), and the number and kind of shares subject to
the Stock Option and/or the exercise price per share will be adjusted. The determination of the Board or a duly appointed Compensation
Committee thereof regarding any adjustment will be final and conclusive.

 

10. No Guarantee
of Continued Service. OPTIONEE ACKNOWLEDGES AND AGREES THAT THE VESTING OF SHARES PURSUANT TO THE VESTING SCHEDULE HEREOF IS
EARNED ONLY BY CONTINUING THE COMPANY RELATIONSHIP OR BUSINESS RELATIONSHIP AT THE WILL OF THE COMPANY (NOT THROUGH THE ACT OF
BEING ENGAGED, BEING GRANTED THIS OPTION OR ACQUIRING SHARES HEREUNDER). OPTIONEE FURTHER ACKNOWLEDGES AND AGREES THAT THIS AGREEMENT,
THE TRANSACTIONS CONTEMPLATED HEREUNDER AND THE VESTING SCHEDULE SET FORTH HEREIN DO NOT CONSTITUTE AN EXPRESS OR IMPLIED PROMISE
OF CONTINUED THE COMPANY RELATIONSHIP FOR THE VESTING PERIOD, FOR ANY PERIOD, OR AT ALL, AND SHALL NOT INTERFERE IN ANY WAY WITH
OPTIONEE’S RIGHT OR THE COMPANY’S RIGHT TO TERMINATE THE RELATIONSHIP AT ANY TIME, WITH OR WITHOUT CAUSE.

 

11. Other Restrictions.

 

11.1 Board Discretionary
Action. The exercise of the Stock Option shall be subject to the requirement that, if at any time the Board or its Compensation
Committee, if any, shall determine that (i) the listing, registration or qualification of the shares of Common Stock subject or
related thereto upon any securities exchange or under any state or federal law, or (ii) the consent or approval of any government
regulatory body or (iii) an agreement by the Optionee with respect to the disposition of shares of Common Stock is necessary or
desirable as a condition of, or in connection with, such exercise or the delivery or purchase of shares pursuant thereto, then
in any such event, such exercise shall not be effective unless such listing, registration, qualification, consent, or approval
or agreement shall have been effected or obtained free of any conditions not acceptable to the Board or its Compensation Committee,
if any.

 

11.2 Restrictions
on Grant of the Option and Issuance of Shares. The grant of the Option and the issuance of shares of Stock upon exercise
of the Stock Option shall be subject to compliance with all applicable requirements of federal, state or foreign law with respect
to such securities. The Stock Option may not be exercised if the issuance of shares of Stock upon exercise would constitute a violation
of any applicable federal, state or foreign securities laws or other law or regulations or the requirements of any stock exchange
or market system upon which the Stock may then be listed. THE OPTIONEE IS CAUTIONED THAT THE STOCK OPTION MAY NOT BE EXERCISED
UNLESS THE FOREGOING CONDITIONS ARE SATISFIED. ACCORDINGLY, THE OPTIONEE MAY NOT BE ABLE TO EXERCISE THE OPTION WHEN DESIRED EVEN
THOUGH THE STOCK OPTION IS VESTED. Questions concerning this restriction should be directed to the Company’s General Corporate
Counsel or the Chief Financial Officer of the Company. The inability of the Company to obtain from any regulatory body having jurisdiction
the authority, if any, deemed by the Company’s legal counsel to be necessary to the lawful issuance and sale of any shares
subject to the Stock Option shall relieve the Company of any liability in respect of the failure to issue or sell such shares as
to which such requisite authority shall not have been obtained. As a condition to the exercise of the Stock Option, the Company
may require the Optionee to satisfy any qualifications that may be necessary or appropriate, to evidence compliance with any applicable
law or regulation and to make any representation or warranty with respect thereto as may be requested by the Company.

 

    	 	6	 

     

    

 

11.3 Legends.
The Company may at any time place legends referencing any applicable federal, state or foreign securities law restrictions
on all certificates representing shares of stock subject to the provisions of this Agreement. The Optionee shall, at the request
of the Company, promptly present to the Company any and all certificates representing shares acquired pursuant to the Stock Option
in the possession of the Optionee in order to carry out the provisions of this Section. The Company may, but will in no event be
obligated to, register any securities issuable upon the exercise of all or any portion of the Stock Option pursuant to the Securities
Act of 1933 (as now in effect or as hereafter amended) or to take any other affirmative action in order to cause the exercise of
the Stock Option or the issuance of shares pursuant thereto to comply with any law or regulation of any governmental authority.
The certificates representing shares issued to Optionee hereunder shall bear such legends as Company determines appropriate referring
to restrictions on the transfer of such shares imposed by this Agreement and such other legends as are required or appropriate
under applicable law.

 

11.4 Trading
Restrictions. The Company may establish periods from time to time during which the Optionee’s
ability to engage in transactions involving the Company’s stock is subject to specific restrictions (“Restricted
Periods”). Notwithstanding any other provisions herein, the Optionee may not exercise
Stock Options during an applicable Restricted Period unless such exercise is specifically
permitted by the Company (in its sole discretion). The Optionee may be subject to a Restricted Period for any reason that the Company
determines appropriate, including, Restricted Periods generally applicable to employees or groups of employees or Restricted Periods
applicable to the Optionee during an investigation of allegations of misconduct or conduct detrimental to the Company by the Optionee.

 

12. Notices. 

 

12.1 Any
notice or other communication required or permitted pursuant to this Agreement shall be in writing and addressed as follows:

 

If to the Company:

 

SolarWindow Technologies, Inc.

300 Main Street

Suite 6

Vestal, New York 13850

Attention: Harmel S. Rayat, Chairman
of the Board

Email: hsr@solarwindow.com

 

 

If to the Optionee, to the following address:

 

Vector Asset
Management, Inc.

700 - 688 West Hastings Street

Vancouver, BC V6B 1P1

Attention: President & CEO

JSBhogal@vectorasset.com

 

    	 	7	 

     

    

 

 or, to such other address or facsimile
number as any Party shall have furnished to the other in writing in accordance with this Section 12.

 

12.2 Notices sent
in accordance with this Section shall be deemed effectively given: (a) when received, if delivered by hand (with written confirmation
of receipt); (b) when received, if sent by a nationally recognized overnight courier (receipt requested); (c) on the date sent
by facsimile or e-mail (in each case, with confirmation of transmission), if sent during normal business hours of the recipient,
and on the next Business Day if sent after normal business hours of the recipient; or (d) on the third (3rd) Business Day after
the date mailed, by certified or registered mail, return receipt requested, postage prepaid.

 

13. Effect of Agreement.
Except as otherwise provided hereunder, this Agreement shall be binding upon and shall inure to the benefit of any successor
or successors of the Company, and to any transferee or successor of the Optionee pursuant to Section 6.

 

14. Severability.
The invalidity or enforceability of any provision of this Agreement shall not affect the validity or enforceability of any
other provision of this Agreement. If the final judgment of a court of competent jurisdiction declares that any provision of this
Agreement is invalid or unenforceable, the parties hereto agree that the court making the determination of invalidity or unenforceability
shall have the power, and is hereby directed, to reduce the scope, duration or area of the provision, to delete specific words
or phrases and to replace any invalid or unenforceable provision with a provision that is valid and enforceable and that comes
closest to expressing the intention of the invalid or unenforceable provision and this Agreement shall be enforceable as so modified.

 

15. Conflicts and
Interpretation. This Agreement is subject to all the terms, conditions and provisions of the Plan. In the event of any conflict
between this Agreement and the Plan, the Plan shall control. In the event of any ambiguity in this Agreement, any term which is
not defined in this Agreement, or any matters as to which this Agreement is silent, the Plan shall govern including, without limitation,
the provisions thereof pursuant to which the Board or its Compensation Committee, if any has the power, among others, to (i) interpret
the Plan, (ii) prescribe, amend and rescind rules and regulations relating to the Plan and (iii) make all other determinations
deemed necessary or advisable for the administration of the Plan.

 

16. Headings. The
headings of Sections herein are included solely for convenience of reference and shall not affect the meaning or interpretation
of any of the provisions of this Agreement.

 

17. Amendment. This
Agreement may not be modified, amended or waived except by an instrument in writing signed by both parties hereto. The waiver by
either party of compliance with any provision of this Agreement shall not operate or be construed as a waiver of any other provision
of this Agreement, or of any subsequent breach by such party of a provision of this Agreement.

 

18. Term. 

 

18.1The
term of this Agreement is six years from the Grant Date, unless terminated prior to such date in accordance with the provisions
herein. The Stock Option shall terminate and may no longer be exercised on the first to occur of (i) the Option Expiration
Date; (ii) the last date for exercising the Option following termination of the Company Relationship as described in Sections
4 and 5; (iii) under the circumstances described in Section 18.2 below; or (iv) a Change in Control
to the extent provided in Section 3.

 

    	 	8	 

     

    

 

18.2 Notwithstanding
any other provision of this Agreement, after voluntary or involuntary termination of the Company Relationship for any reason, the
Optionee or VAMI, in the sole judgment of the Company, breaches any of the provisions of the Consulting Agreement surviving termination
thereof, then to the greatest extent permitted by applicable law: to the extent this Option has not yet been exercised, it shall
immediately cease to be exercisable and shall be, and shall be deemed, cancelled.

 

19. Counterparts.
This Agreement may be executed in any number of counterparts, each of which when so executed and delivered shall be deemed
an original, and all of which together shall constitute one and the same agreement. Execution of a facsimile or scanned copy will
have the same force and effect as execution of an original, and a facsimile or scanned signature will be deemed an original and
valid signature.

 

20. Other Agreements.
Nothing in this Agreement alters, amends, supersedes, or modifies any other agreements, or contractual provisions of other
agreements, between the Participant and the Company (including but not limited to consulting agreements, nondisclosure agreements
or restrictive covenants), all such other agreements being wholly separate and apart from this Agreement.

 

21. Interpretation.
For purposes of this Agreement, (a) the words “include,” “includes,” and “including” shall
be deemed to be followed by the words “without limitation”; (b) the word “or” is not exclusive; and (c)
the words “herein,” “hereof,” “hereby,” “hereto,” and “hereunder” refer
to this Agreement as a whole. Unless the context otherwise requires, references herein: (x) to Sections, Exhibits and Schedules
refer to the Sections of, and Exhibits and Schedules attached to, this Agreement; (y) to an agreement, instrument, or other document
means such agreement, instrument, or other document as amended, supplemented, and modified from time to time to the extent permitted
by the provisions thereof; and (z) to a statute means such statute as amended from time to time and includes any successor legislation
thereto and any regulations promulgated thereunder. Any Exhibits or Schedules referred to herein shall be construed with,
and as an integral part of, this Agreement to the same extent as if they were set forth verbatim herein.

 

22. Laws Applicable
to Construction. The interpretation, performance and enforcement of this Agreement shall be governed by the laws of the State
of Nevada without reference to principles of conflict of laws, as applied to contracts executed in and performed wholly within
the State of Nevada.

 

[SIGNATURE PAGE FOLLOWS]

 

 

 

 

 

 

 

 

    	 	9	 

     

    

 

IN WITNESS WHEREOF,
the Company and the Optionee have executed and delivered this Agreement effective as of the date first above written to be effective
as the Effective Date.

 

 

 

	
         

        VECTOR ASSET MANAGEMENT, INC.

        For purpose of acknowledging its assignment
        and transfer of the Stock Option to the Optionee and its directive to issue the Stock Option directly to and in the name of the
        Optionee.

	 
	 
	 
	 
	By:	 	 
	Name:	Jatinder S. Bhogal
	Title:	President
	 	 
	 	 
	OPTIONEE
	 
	 
	 
	 
	 	 	 
	Name:	Jatinder S. Bhogal
	 
	 
	SOLARWINDOW TECHNOLOGIES, INC.
	 
	 
	 
	 
	By:	 	 
	Name: 	Steve Yan-Klassen
	Title:	Chief Financial Officer

 

 

 

 

 

 

 

 

    	 	10	 

     

    

 

Exhibit A

To the Stock Option Agreement Dated as of
June 29 , 2020

Between

SolarWindow Technologies, Inc. and Jatinder
S. Bhogal

__________

 

Form of Notice of Exercise of Non-statutory
Stock Option

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	11	 

     

    

 

Form of Notice of Exercise of Non-statutory
Stock Option

 

 

SolarWindow Technologies, Inc.

300 Main Street

Suite 6

Vestal, New York 13850

Attention: Harmel S. Rayat, Chairman of
the Board

Email: hsr@solarwindow.com

 

Dear Sir:

 

This letter constitutes
an unconditional and irrevocable notice that I hereby exercise [all] [a portion] of the Stock Option(s) granted to me by SolarWindow
Technologies, Inc., a Nevada corporation (the “Company”) on June 8, 2020 (“date of grant”),
effective as of July 1, 2020 (“effective date”) at a fair market value of US$ ______ per Share (equal to the
closing price of the Shares of the Company’s Common Stock on the date of grant). Pursuant to the terms of such Stock Option(s),
I wish to purchase _______________ Shares of the Common Stock covered by such Stock Option(s) at the Exercise Price(s) of US$ ______
per Share (based on the closing price on the trading immediately preceding the date of exercise of this option) or $________________in
the aggregate.

 

Payment being made
as follows pursuant to (check as appropriate):

 

{ }Section 3(b)(i);

{ }Section 3(b)(ii);

{ }Section 3(b)(iii)
and (c); 

{ }Section 3(b)(iv)

 

 If pursuant to
Section 3(b)(iii) and (c) of the Stock Option Grant Agreement dated as of the Effective Date between me and the Company
and calculated as follows (and subject to the Company’s confirmation):

 

 

 

 

 

 

 

These Shares should be delivered as follows:

 

	Name:	 	 	 
	 	 	 	 
	Address:	 	 	 
	 	 	 	 
	 	 	 	 
	Social Security or TIN:	 	 	 

 

    	 	12	 

     

    

 

I represent that I
will not dispose of such Shares in any manner that would involve a violation of applicable securities laws. By this exercise, I
agree (i) to provide such additional documents as you may require pursuant to the terms of the 2006 Incentive Plan, and (ii) to
provide for the payment by me to you (in the manner designated by you) of your withholding obligation, if any, relating to the
exercise of this option.

 

	Dated:	 	 	By:	 	 
	 	 	 	 	 	 
	 	 	 	Name:	 	 
	 	 	 	 	 	 
	 	 	 	Email:	 	 
	 	 	 	 	 	 
	 	 	 	Phone: 	 	 

 

 

 

 

 

 

 

 

13

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}]]